Coldstream Capital Management Inc Denali Therapeutics Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 145 shares of DNLI stock, worth $2,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
145Holding current value
$2,318% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
238Shares Held
124MCall Options Held
66.3KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$211 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$193 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$189 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$182 Million0.03% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$85.6 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.15B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...